FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person * Magow Rajesh (Last) (First) (Middle) CM 717 B, THE CAMELLIAS DLF PHASE V GOLF LINKS, (Street) GURGAON 122009 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol MakeMyTrip Ltd [ MMYT ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Group Chief Executive Officer
	3. Date of Earliest Transaction (Month/Day/Year) 11/03/2026
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/03/2026		M		20,000	A	$ 0.0005	20,000	D
Ordinary Shares	11/03/2026		S		20,000	D	$ 45.25 (1)	0	D
Ordinary Shares	11/04/2026		M		10,000	A	$ 0.0005	10,000	D
Ordinary Shares	11/04/2026		S		10,000	D	$ 50.11 (2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$ 0.0005	11/03/2026		M			20,000	(3)	(3)	Ordinary Shares	20,000	$ 0	1,413,663	D
Restricted Stock Units	$ 0.0005	11/04/2026		M			10,000	(4)	(4)	Ordinary Shares	10,000	$ 0	1,403,663	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $45.20 to $45.45. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.

2. The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $50.01 to $50.37. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.

3. Following the transaction dated November 3, 2026, 1,384,185 Restricted Stock Units (RSUs) are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 ordinary shares subject to the achievement of certain performance-based vesting conditions.

4. Following the transaction dated November 4, 2026, 1,374,185 RSUs are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 Ordinary Shares subject to the achievement of certain performance-based vesting conditions.

	/s/ Rajesh Magow	11/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.